Axovant shares are trading lower. The company announced it sees delayed enrollment in its Parkinson's study due to delays in manufacturing.
Axovant shares are trading lower. The company announced it sees delayed enrollment in its Parkinson's study due to delays in manufacturing.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.